症状性复发/进展性颅咽管瘤的手术治疗:是否存在金标准方法?
该研究回顾性分析了2015至2023年在本中心初治的31例活检证实的复发/进展性颅咽管瘤患者,比较有无复发患者的人口学与临床特征。15例(48.4%)行经鼻/经蝶内镜手术,其余16例行显微镜经颅或神经内镜手术;治疗后复发率与事件发生率分别为48.4%和32.3%。有无复发患者在年龄、肿瘤大小、位置、性别、手术方式及钙化或脑积水方面均无统计学显著差异(P>0.05)。
要点
- 31例复发/进展性颅咽管瘤中,15例(48.4%)接受经鼻/经蝶内镜手术,16例接受显微镜经颅或神经内镜手术。
- 治疗后复发率为48.4%,事件发生率为32.3%,有无复发患者各特征比较P>0.05。
- 作者认为复发颅咽管瘤处理过于复杂,无法纳入标准治疗流程,手术应个体化。
核心结论
- 复发颅咽管瘤的处理过于复杂,无法纳入标准治疗流程。
- 作者认为手术应个体化,根据患者症状和影像学表现制定方案,这可能是更灵活、高效且安全的方法。
研究设计与样本
- 回顾性综述了2015至2023年在本中心初治的31例活检证实的复发/进展性颅咽管瘤患者。
- 比较有无复发患者的人口学和临床资料,包括年龄、性别、肿瘤位置、病灶大小和特征、影像学表现及内分泌、神经和眼科问题。
主要发现
- 31例中15例(48.4%)行经鼻/经蝶内镜手术,其余16例行显微镜经颅或神经内镜手术。
- 治疗后复发和事件(与当前病情相关的任何非复发的医疗状况)分别见于48.4%和32.3%的病例。
- 有无复发患者在年龄、肿瘤尺寸、肿瘤位置、性别分布、手术方式或钙化/脑积水存在方面均无统计学显著差异(P>0.05)。
- 总生存期最高为25年,最低为6个月。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The standard treatment for craniopharyngiomas (CPs) involves either initial gross total resection or subtotal resection with adjuvant radiotherapy. However, there is no consensus regarding the management of recurrent cases. We reviewed a series of patients with CP to evaluate the characteristics of patients with recurrent/progressing CP. METHODS: We retrospectively reviewed 31 patients with biopsy-proven recurrent/progressed CP who were initially operated on at our clinic from 2015 to 2023. Demographic and clinical data, including age, sex, tumor localization, lesion size and features, radiologic findings, and endocrine, neurologic, and ophthalmologic issues, were compared between those with and without recurrence. RESULTS: Fifteen out of 31 patients (48.4%) underwent transnasal/transsphenoidal endoscopic surgery; the remaining 16 underwent microscopic transcranial or neuroendoscopic surgery. After treatment, recurrence, and events (any medical condition related to the patient's current condition other than recurrence) were observed in 48.4% and 32.3% of the cases, respectively. There were no statistically significant disparities between patients with and without recurrence in terms of age, tumor dimensions, tumor localization, gender distribution, surgical modality, or the presence of calcifications or hydrocephalus (P > 0.05). The highest and lowest overall survival was 25 years and 6 months, respectively. CONCLUSIONS: The management of recurrent CP is too complicated to fit into a standard treatment algorithm. Therefore, surgical treatment for these patients should be individualized and planned according to patient symptoms and radiologic findings, which is presumably a more versatile, efficient, and safe approach for recurrent CPs.
引用
- Ozgural O, Bayatli E, Eray HA, et al. Surgical Management of Symptomatic Recurrent/Progressive Craniopharyngioma: Is There a Gold-Standard Approach? World Neurosurg. 2024. PMID: 39522815. doi:10.1016/j.wneu.2024.10.134
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。